1-氯-2-(4-甲基苄基)苯 | 106731-04-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-氯-2-(4-甲基苄基)苯
• 英文名称: 1-chloro-2-(4-methylbenzyl)benzene
• 英文别名: (2-chloro-phenyl)-p-tolyl-methane；(2-Chlor-phenyl)-p-tolyl-methan；1-Chloro-2-[(4-methylphenyl)methyl]benzene
• CAS: 106731-04-8
• 化学式: C₁₄H₁₃Cl
• 分子量: 216.71
• InChiKey: IEJAFJPJCOPMIW-UHFFFAOYSA-N

物化性质

• 沸点：
  146-147 °C(Press: 6 Torr)
• 密度：
  1.099±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  1-氯-2-(4-甲基苄基)苯 、 alkaline earth salt of/the/ methylsulfuric acid 在 吡啶 作用下， 生成 2-(4-methylbenzyl)benzonitrile
  参考文献：
  名称：

  The Synthesis and Cyclization of Some 2-(Substituted Benzyl)-benzophenones^1,2

  摘要：

  DOI：

  10.1021/ja01155a014
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 磷化氢 、 碘 、 溶剂黄146 作用下， 生成 1-氯-2-(4-甲基苄基)苯
  参考文献：
  名称：

  The Synthesis and Cyclization of Some 2-(Substituted Benzyl)-benzophenones^1,2

  摘要：

  DOI：

  10.1021/ja01155a014

文献信息

• Superacid BF₃–H₂O promoted benzylation of arenes with benzyl alcohols and acetates initiated by trace water
  作者：Shuting Zhang、Xiaohui Zhang、Xuege Ling、Chao He、Ruofeng Huang、Jing Pan、Jiaqiang Li、Yan Xiong

  DOI：10.1039/c4ra04059g

  日期：——

  An efficient in situ prepared superacid BF₃–H₂O promoted benzylation of arenes using benzyl alcohols and acetates achieves various diarylalkanes.

  一种高效的原位制备的超强酸BF3-H2O促进的芳烃苄基化反应，使用苄醇和醋酸酯制备各种二芳基烷烃。
• Exploiting Boron-Zinc Transmetallation for the Arylation of Benzyl Halides: What are the Reactive Species?
  作者：Robin B. Bedford、Nicholas J. Gower、Mairi F. Haddow、Jeremy N. Harvey、Joshua Nunn、Rukeme A. Okopie、Rosalind F. Sankey

  DOI：10.1002/anie.201202219

  日期：2012.5.29

  One step Beyond: The transmetallation reactions of ArB(OH)2 and Ar3B3O3 with Et2Zn are far more complicated than previously supposed, with solvent‐dependent equilibria between ArB(OY)2 at one side and [RZn(solv)3][BR4] at the other (see picture). While the role of the highly reactive organozinc cation has not been implicated before, its importance for the activation of an otherwise sluggish class of

  一个步骤 乙eyond：为ArB的金属转移反应（OH）2和Ar 3乙3 ö 3用Et 2的Zn被远远超过预先设想复杂化，具有为ArB（OY）之间依赖溶剂平衡2在一侧和[RZN （solv）3 ] [BR 4 ]在另一个（参见图片）。尽管以前没有涉及高反应性有机锌阳离子的作用，但显示了其对于活化否则为慢的一类亲电子试剂的重要性。
• Benzylation of arenes with benzyl ethers promoted by the in situ prepared superacid BF3–H2O
  作者：Yu Li、Yan Xiong、Xueming Li、Xuege Ling、Ruofeng Huang、Xiaohui Zhang、Jianchun Yang

  DOI：10.1039/c4gc00005f

  日期：——

  An efficient and environmentally friendly benzylation of arenes with benzyl ethers as benzyl donors using BF3–Et2O to generate in situ the superacid BF3–H2O as an efficient promotor has been described. A wide variety of functional groups have been investigated and found to be compatible to give the desired diarylmethanes in yields of up to 99%. The crucial role of the moisture content in this transformation has been demonstrated by detailed investigations.

  一种高效且环保的芳烃苄基化反应，采用苄基醚作为苄基供体，并使用BF3–Et2O原位生成超酸BF3–H2O作为高效促进剂。研究发现多种功能团具有良好的兼容性，能够获得最高达99%的期望二芳基甲烷产率。通过详细的研究，证明了水分含量在这一转化过程中的关键作用。
• Cobalt-Catalyzed Formation of Functionalized Diarylmethanes from Benzylmesylates and Aryl Halides
  作者：Bhoomireddy Rajendra Prasad Reddy、Sushobhan Chowdhury、Audrey Auffrant、Corinne Gosmini

  DOI：10.1002/adsc.201800468

  日期：2018.8.17

  A simple cobalt‐catalyzed reductive coupling protocol allowing the synthesis of functionalized diarylmethanes from benzyl mesylate is described. The possibility to directly use the benzyl alcohol as a result of a two‐step reaction is also presented. This method tolerates a variety of functional groups. A benzyl radical is likely involved.

  描述了一种简单的钴催化还原偶联方案，可以从甲磺酸苄酯合成功能化的二芳基甲烷。还提出了通过两步反应直接使用苯甲醇的可能性。该方法可以耐受多种功能基团。可能涉及苄基。
• CRYSTAL STRUCTURES OF SGLT2 INHIBITORS AND PROCESSES FOR PREPARING SAME
  申请人：Gougoutas Z. Jack

  公开号：US20080004336A1

  公开（公告）日：2008-01-03

  The present invention relates to physical crystal structures of a compound of the formula I: wherein R 1 , R 2 , R 2a , R 3 and R 4 are as defined herein, especially pharmaceutical compositions containing structures of compound I or II, processes for preparing same, intermediates used in preparing same, and methods of treating diseases such as diabetes using such structures.

  本发明涉及化合物I的物理晶体结构，其中R1、R2、R2a、R3和R4如本文所定义，特别是含有化合物I或II结构的药物组合物，制备同样的过程，用于制备同样的中间体，以及利用这些结构治疗糖尿病等疾病的方法。